Jacobi Capital Management LLC Glaukos Corp Transaction History

Jacobi Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $12,081 - $17,097	-300 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$70.43 - $97.42 $33,454 - $46,274	-475 Reduced 61.29%	300 $25,000
Q4 2020 Feb 08, 2021	SELL	$48.9 - $75.26 $11,002 - $16,933	-225 Reduced 22.5%	775 $58,000
Q2 2020 Jul 27, 2020	BUY	$28.78 - $46.83 $28,780 - $46,830	1,000 New	1,000 $38,000

342

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.84B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.